person · Reporting owner
Weaver Aaron Ngoc Dung
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Interactive Strength, Inc.TRNR · Entity 8371 | Director | June 07, 2023 | June 09, 2023 |
| Neuphoria Therapeutics Inc.BNOX · Entity 7639 | Director | July 01, 2024 | July 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Interactive Strength, Inc.
Report date June 07, 2023 · Filed June 09, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.86 · Expires 2033-06-07 | Direct | 112,401 |
Reported balance
After 2023-06-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-07 · Grant · Acquired 60,000 · Balance 112,401 F1: Represents an initial option to purchase 60,000 shares of common stock, vesting if and when the Issuer's per share price reaches certain milestones, subject to the reporting person's continued service with the Issuer as a director through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an initial option to purchase 60,000 shares of common stock, vesting if and when the Issuer's per share price reaches certain milestones, subject to the reporting person's continued service with the Issuer as a director through the applicable vesting date.
Neuphoria Therapeutics Inc.
Report date July 01, 2024 · Filed July 08, 2024
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2023 Filed Jun 9, 2023 19:45 UTC | Interactive Strength, Inc. TRNR · Entity 8371 | GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $4.86 | $0.00 |
DisclosureSEC source: 0000899243-23-015141 · doc4.xml · derivative · entry 1 Weaver Aaron Ngoc Dung · CIK 0001961347 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,401 Underlying: Common Stock · 60,000 shares Expires 2033-06-07 F1 · derivative.exercise_date: Represents an initial option to purchase 60,000 shares of common stock, vesting if and when the Issuer's per share price reaches certain milestones, subject to the reporting person's continued service with the Issuer as a director through the applicable vesting date. Read SEC document |
| April 28, 2023 Filed Apr 28, 2023 22:45 UTC | Interactive Strength, Inc. TRNR · Entity 8371 | GrantStock Option (right to buy) · Derivative | 52,401 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0000899243-23-011903 · doc4.xml · derivative · entry 1 Weaver Aaron Ngoc Dung · CIK 0001961347 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,401 Underlying: Common Stock · 52,401 shares Expires 2033-04-28 F1 · derivative.exercise_date: Represents an initial option to purchase 52,401 shares of common stock, vesting in equal annual installments over three years, subject to the reporting person's continued service with the Issuer as a director through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.